Substance / Medication

Sulfacetamide

Overview

Active Ingredient
sulfacetamide
RxNorm CUI
10169

Indications

INDICATIONS: Sodium Sulfacetamide 9% - Sulfur 4% Wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Labeler: ACELLA PHARMACEUTICALSUpdated: 2024-01-10T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

CONTRAINDICATIONS: Sodium Sulfacetamide 9% - Sulfur 4% Wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or ony other component of this preparation. Sodium Sulfacetamide 9% - Sulfur 4% Wash is not to be used by patients with kidney disease.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Postoperative trachomatous trichiasis: a systematic review and meta-analysis study.
Adimassu Nebiyat Feleke, Assem Abel Sinshaw, Fekadu Sofonias Addis · Int Health · 2023
PMID: 36852770Meta-AnalysisFull text (PMC)
Global Trends in Blindness and Vision Impairment Resulting from Corneal Opacity 1984-2020: A Meta-analysis.
Wang Erin Y, Kong Xiangrong, Wolle Meraf et al. · Ophthalmology · 2023
PMID: 36963570Meta-AnalysisFull text (PMC)
Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis.
Damian Laura, Pamfil Cristina, Bucșa Camelia et al. · Clin Exp Rheumatol · 2022
PMID: 35238768Meta-Analysis
Community-level trachoma ecological associations and the use of geospatial analysis methods: A systematic review.
Burgert-Brucker Clara R, Adams Molly W, Mingkwan Pia et al. · PLoS Negl Trop Dis · 2022
PMID: 35395003Meta-AnalysisFull text (PMC)
Interventions for Neglected Tropical Diseases Among Children and Adolescents: A Meta-analysis.
Naqvi Fatima Abbas, Das Jai K, Salam Rehana A et al. · Pediatrics · 2022
PMID: 35503336Meta-Analysis
Distribution, Prevalence, and Causative Agents of Fungal Keratitis: A Systematic Review and Meta-Analysis (1990 to 2020).
Ahmadikia Kazem, Aghaei Gharehbolagh Sanaz, Fallah Bahareh et al. · Front Cell Infect Microbiol · 2021
PMID: 34513726Meta-AnalysisFull text (PMC)
Effectiveness of Cryopreserved Amniotic Membrane Transplantation in Corneal Ulceration: A Meta-Analysis.
Liu Jinghua, Li Linghan, Li Xuan · Cornea · 2019
PMID: 30702468Meta-Analysis
Infectious keratitis and orthokeratology lens use: a systematic review.
Kam Ka Wai, Yung Wing, Li Gabriel Ka Hin et al. · Infection · 2017
PMID: 28534320Meta-Analysis
Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea.
Torok Helen M, Webster Guy, Dunlap Frank E et al. · Cutis · 2005
PMID: 16047874Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sulfacetamide (substance)
SNOMED CT
372676007
UMLS CUI
C0038670
RxNorm CUI
10169
Labeler
ACELLA PHARMACEUTICALS

Clinical Data

This intervention maps to 5 entities in the Ltrl knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Sulfacetamide: Uses, Evidence & Side Effects | Ltrl